Provenge Cancer Vaccine: Are 4 Months of Life Worth 100K? - ABC News

Although there should be excitement around Provenge Cancer Vaccine's ability to extend life in advanced prostate cancer patients for huge bulks, its scientific direction might suggest that the medical community is finally getting a handle on cancer without using draconian treatments. Science has learned how to teach our bodies to knock out the cancer with a treatment tailored specifically to the patient's own body and not seeking some one size fit all solution. There is also room for a lesson on the pricing of Provenge: when a product is overpriced in the marketplace it will draw in substitutes. Also holding life and death of cancer patients in the hands of the moneychangers may kindle ramped industrial espionage to steal research for some nations may have little scruples when it looks like the fat cats got the medical advantage over commoners.